Search for Clinical Trial Results

Sponsored By

Biliary Tract Cancer - 81 Studies Found

Status Study
Completed Study Name: A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers
Condition:
  • Pancreatic Cancer
  • Biliary Cancer

Date: 2012-07-24
Interventions:
  • Drug: Gemcitabine
  • Drug: 5-FU

Terminated Study Name: Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study
Condition: Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
Date: 2013-09-10
Interventions:
  • Drug: Cisplatin day1 and day8

Completed Study Name: Study of Sulfatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma
Condition: Biliary Tract Cancer
Date: 2016-11-11
Interventions: Drug: Sulfatinib Patients receive oral Sulfatinib at a dose of 300mg/d within 1 hour after breakfast (on
Not yet recruiting Study Name: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
Condition: Biliary Tract Cancer
Date: 2017-04-12
Interventions:
  • Drug: Pembrolizumab (MK-3475)

Completed Study Name: XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
Condition: Biliary Tract Cancer
Date: 2014-11-24
Interventions:
  • Drug: capecitabine XELOX every
Completed Study Name: Covered Versus Uncovered Biliary Stents for Biliary Malignancies
Condition: Biliary Tract Cancer
Date: 2014-03-26
Interventions:
  • Device: covered biliary stents

Active, not recruiting Study Name: X-MAS Biliary Study With Covered Biliary Stent
Condition: Biliary Tract Cancer
Date: 2013-07-08
Interventions: Device: X-Suit NIR Covered Biliary Stent
Completed Study Name: Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas
Condition: Biliary Tract Cancer
Date: 2012-04-04
Interventions: Drug: Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine HAI of Oxaliplatin and Fluorouracil: Oxaliplat
Terminated Study Name: A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma
Condition: Biliary Tract Cancer
Date: 2009-04-13
Interventions: Drug: "Bevacizumab" in combination with "modified FOLFOX6". Oxaliplatin 85 mg/m2 IV
Not yet recruiting Study Name: Study of SPARC1507
Condition: Advanced Biliary Tract Cancer
Date: 2015-11-03
Interventions:
  • Drug: SPARC1507 The administer
<<< Previous | Next >>>